Mandy and Hunter gave a terrific presentation today at the University of Texas San Antonio (UTSA) Annual RISE/MARC Symposium. While the details of their study will be described in an upcoming manuscript, we are very proud of the teamwork and initiative shown by Mandy and Hunter on this complex series of experiments studying bone marrow stem cells in genetically-engineered mice!Unraveling rhabdomyosarcoma, osteosarcoma, dipg and medulloblastoma using engineering, biomedical, and translational research tools.
Friday, September 26, 2008
Mandy and Hunter present at the RISE/MARC Symposium
Mandy and Hunter gave a terrific presentation today at the University of Texas San Antonio (UTSA) Annual RISE/MARC Symposium. While the details of their study will be described in an upcoming manuscript, we are very proud of the teamwork and initiative shown by Mandy and Hunter on this complex series of experiments studying bone marrow stem cells in genetically-engineered mice!Thursday, September 25, 2008
Welcoming Rotation Student, Lilly Paredes
Lilliana "Lilly" Paredes graduated from the University of Texas El Paso with a major in Biology this past Spring. As an undergraduate, Lilly participated in a molecular parasitology research laboratory at UTEP. This exciting and productive experience inspired her to pursue a research career. As a first year graduate student in the Graduate School of Biomedical Sciences at UTHSCSA, Lilly's current interests include Microbiology, Genetics and Pharmacology. During her Fall rotation in our laboratory, Lilly will be co-mentored by Koichi and Charles. [pictured above: Lilly on a recent trip to NYC.]
Saturday, September 13, 2008
Today is National Childhood Cancer Awareness Day
National Childhood Cancer Awareness Day draws attention to more than 12,000 children are diagnosed with cancer each year in the United States with many fold more children diagnosed across the Americas and worldwide. While outcome for the most common form of childhood leukemia has improved from a 5% cure rate forty-five years ago to more than 90% now, many other childhood cancers have cure rates are less desirable and unimproved for decades. New research and new targeted therapies are thus needed.The bi-partisan Allard-Clinton "National Childhood Cancer Awareness Day" Resolution was sponsored by Senators Wayne Allard (CO) and Hillary Rodham Clinton (NY). See also the Curesearch story.
[ pictured above: The Greehey Children's Cancer Research Institute (GCCRI), created by means of a $200M endowment by the Texas legislature. The GCCRI is the most substantial public investment in childhood cancer research since the founding of the St Jude Children's Research Hospital in 1962 (more than 4 decades ago). Click here to contribute to childhood cancer research. ]
Monday, September 1, 2008
In Memoriam: Stephen J. Qualman, M.D.
We are very sad to learn of the passing of Dr. Stephen Qualman, a pioneer in pediatric sarcoma research and a advocate of multi-disciplinary collaborations. Steve's own 13 month battle with pancreatic cancer is said to have ended Saturday.For more than 24 years Steve has been a leader in pediatric oncology pathology. He founded the Biopathology Center at Nationwide Children's Hospital in Columbus, Ohio, which is known to be a prototype for national biorepositories. He also had a very active and productive rhabdomyosarcoma research program. We felt privileged to work with him on collaborations past and present. He was everyone's friend, and truely believed that childhood cancer could be cured. His selfless efforts over so many years attest to this. Appropriately, Steve was awarded the American Cancer Society Hero of Hope Medal of Honor just days ago. His example will be remembered by many.
Steve will be greatly missed by his colleagues, and our hearts go out to his family.
[picture source: http://www.osuccc.osu.edu/9187.cfm?person_id=114 ]
Monday, August 18, 2008
Scott Carter's Heroes Golf Classic
This weekend was the Fifteenth Anniversary Scott Carter's Heroes Big Show and Golf Classic to benefit Children's Cancer Research. These events in Tulsa, sponsored by the Scott Carter Foundation, benefit CureSearch research fellowships as well as a research fellowship in our laboratory. Koichi Nishijo, MD, PhD, was introduced as the 2008 Scott Carter Fellow at GCCRI. Koichi and I had a lot of fun meeting the organizers and participants of this event. Scott's parents, Mike and Paula, brother Cason and sister Liz, and grandparents Paul and Crys (and numerous family friends and advocates) are nothing short of tireless in their dedication to this cause. Their support of me as a Scott Carter Fellow in 1999 - 2000 made it possible for me to begin my research career in the laboratory of 2007 Nobel laureate Mario Capecchi, and the project that the Scott Carter Foundation sponsored is featured in Mario's Nobel prize lecture. I am deeply grateful to the Foundation's ongoing support to train new scientists in the pursuit of better treatments for childhood cancer.[ pictured from left to right: Koichi, Dr. Paul Ol'Dad Compton (Scott's grandfather), and Charles ]
Friday, August 15, 2008
Welcoming Imran !
We're excited to welcome medical student Imran Aslam to our laboratory. Imran graduated from the University of Houston in May 2008 with a B.S. in Biology and a minor in Chemistry. He has been interested in medicine from a young age, having had the unique opportunity to shadow Dr. Jonathan C. Trent at his MD Anderson clinic during high school and college. Imran joined Dr. Trent's sarcoma research laboratory as a college junior. He is grateful to his mentor who allowed him the privilege to work in such a dynamic, focused lab environment. During this time Imran's project was to evaluate the role of the cytokine receptor CXCR4 in small cell sarcoma. Imran is currently a first year medical student at the UT Health Science Center at San Antonio and will continue his research training through the MD with Distinction in Research program as a member of our laboratory.
Monday, August 4, 2008
Rhabdomyosarcoma Therapeutics Study published today in Oncogene
Congratulations to Eri and her co-authors Koichi and Mandy on the publication today of their study, "PDGFR-A is a Therapeutic Target in Alveolar Rhabdomyosarcoma". Our paper was published in the advanced online edition of the journal Oncogene. This study reveals a very promising new category of non-chemotherapy drugs to try in this disease, as we have done in our mouse model. Moving our results to the clinic will require close attention and some further study of how tumors become resistant to this drug class in about 1/3 of cases. These follow-up studies are currently being undertaken by Corrine and Eri. Further description of our study is given on Newswise.[ UPDATE (Nov 2008) The formal version of Eri's article is now available. ]
Subscribe to:
Posts (Atom)